Isoniazid/Pyrazinamide/Rifampicin | m-entrepreneurship.com

Product Name :
Isoniazid/Pyrazinamide/Rifampicin

Search keywords :
Pyrazinamide

drugId :
null

Target Vo:
Fatty acid synthase

Target Vo Short Name :
FAS

Moa_Name:
Fatty acid synthase inhibitors

First Approval Country :
United States

First Approval Date Filter:
1994

Origin Company_Name :
Sanofi

Active Company_Name :
North China Pharmaceutical Hebei Huanuo Co Ltd

Active Indication_Name:
Tuberculosis

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Approved

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
SPI1 Antibody (YA118)
p53 (acetyl K382) Antibody
GSK3 beta Antibody (YA744): GSK3 beta Antibody (YA744) is a non-conjugated and Mouse origined monoclonal antibody about 47 kDa, targeting to GSK3 beta. It can be used for WB,IHC-P,FC assays with tag free, in the background of Human, Mouse, Rat.

Author: Betaine hydrochloride

Related Posts